BRCA1 and breast carcinoma: To validate the therapeutic relevance of KLF4 in breast cancer DNA repair/DNA damage targeting treatment, we have conducted an in vivo mouse xenograft study by using murine 4T1 model, which harbors wild‐type BRCA1 expression (Castle et al, 2014).